Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
Current Opinion in Rheumatology|September 3, 2011
An update on an immune system that goes awry in systemic sclerosisL van Bon, M Cossu, T R D J RadstakeClinical and Experimental Immunology|January 24, 2020
Novel insights into dendritic cells in the pathogenesis of systemic sclerosisT Carvalheiro, M Zimmermann, T R D J Radstake, et al.International Journal of Rheumatology|December 14, 2011
A system out of breath: how hypoxia possibly contributes to the pathogenesis of systemic sclerosisT W van Hal, L van Bon, T R D J RadstakeThe Netherlands Journal of Medicine|September 30, 2010
Gout: a clinical syndrome illustrated and discussedK J Bhansing, L van Bon, M Janssen, et al.Handbook of Experimental Pharmacology|November 26, 2008
Dendritic cells and their potential implication in pathology and treatment of rheumatoid arthritisM H Wenink, W Han, R E M Toes, et al.The Netherlands Journal of Medicine|April 13, 2006
Fc gamma receptor mediated modulation of dendritic cells as a potential strategy in the battle against rheumatoid arthritisM H Wenink, W B van den Berg, P L C M van Riel, et al.FEBS Letters|April 26, 2011
Toll-like receptors in rheumatic diseases: are we paying a high price for our defense against bugs?K C M Santegoets, L van Bon, W B van den Berg, et al.Arthritis and Rheumatism|December 2, 2009
The FAS -670A>G polymorphism influences susceptibility to systemic sclerosis phenotypesJ Broen, P Gourh, B Rueda, et al.Transplant Immunology|May 2, 2017
Serum miRNAs as potential biomarkers for the bronchiolitis obliterans syndrome after lung transplantationK Budding, M Rossato, E A van de Graaf, et al.Annals of the Rheumatic Diseases|May 10, 2005
Dendritic cells, Fc{gamma} receptors, and Toll-like receptors: potential allies in the battle against rheumatoid arthritisT R D J Radstake, A W T van Lieshout, P L C M van Riel, et al.Pageof 5